Cigna Corp
NYSE:CI
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
244.41
340.04
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
CI
stock under the Base Case scenario is
665.7
USD.
Compared to the current market price of 278.95 USD,
Cigna Corp
is
Undervalued by 58%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Cigna Corp.
| US |
|
CVS Health Corp
NYSE:CVS
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
|
| US |
|
Hims & Hers Health Inc
NYSE:HIMS
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Cigna’s heavy reliance on its pharmacy benefit management (PBM) arm, Express Scripts, exposes it to heightened regulatory scrutiny around drug pricing and pharmacy rebates, potentially squeezing margins if new legislation clamps down on PBM profits.
Tough price negotiations and commoditization pressures in the employer-sponsored insurance market could limit opportunities for premium growth, leaving Cigna vulnerable to larger rivals with more diversified offerings.
Accelerated consolidation among key providers and hospitals may weaken Cigna’s bargaining power in certain regions, raising medical costs and eroding the company’s competitiveness in network-based products.
Cigna’s successful integration of Express Scripts provides a one-stop solution covering health insurance and pharmacy benefits, driving cross-selling opportunities and cost synergies to outpace peers on profitability.
A steady shift towards value-based care arrangements and boosted telehealth capabilities positions Cigna to capture demand from employers seeking cost-effective, integrated healthcare solutions for their workforces.
Cigna’s growing set of ancillary businesses, such as behavioral health and international insurance segments, diversifies revenue sources, reduces reliance on U.S. commercial sales, and strengthens its global footprint.
Balance Sheet Decomposition
Cigna Corp
| Cash & Short-Term Investments | 6.9B |
| PP&E | 3.7B |
| Long-Term Investments | 18.5B |
| Other Assets | 128.9B |
| Long Term Debt | 30.9B |
| Other Liabilities | 85.2B |
Wall St
Price Targets
CI Price Targets Summary
Cigna Corp
According to Wall Street analysts, the average 1-year price target for
CI
is 332.04 USD
with a low forecast of 272.7 USD and a high forecast of 396.9 USD.
Dividends
Current shareholder yield for
CI is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CI
stock under the Base Case scenario is
665.7
USD.
Compared to the current market price of 278.95 USD,
Cigna Corp
is
Undervalued by 58%.